周德祥, 2012.

Methods	Allocation: randomised. Blindness: not stated. Duration: 7 days.
Participants	Diagnosis: CCMD‐3 diagnosis of schizophrenia. N = 65. Age: range 18‐60 years. Sex: 36 males, 29 females. History: acute psychotic agitation; length of Illness of 1.1 to 22.3 months. Excluded: pregnancy, serious physical illness, addiction to alcohol or drugs. Setting: inpatients, China*.
Interventions	1. Haloperidol: dose 10 mg/IM/day to 20 mg/IM/day. N = 32. 2. Risperidone: dose 4 mg/oral/day to 6 mg/oral/day + clonazepam dose 2 mg/oral/day to 4 mg/oral/day. N = 33.
Outcomes	Unable to use: Mental state: PANSS total (data not reported). Agitation: PANSS‐EC (data not reported). Adverse events (data not reported).
Notes	*It is not clear if this paper presents the results from one centre of the Fang 2012 multi‐centre trial. Authors contact unavailable.

ACES: Agitation‐Calmness Evaluation Scale
 AIMS: Abnormal Involuntary Movement Scale
 BARS: Behavioural Activity Rating ScaleBAS: Barnes Akathisia Scale
 BPRS: Brief Psychiatric Rating Scale
 CABS: Corrigan Agitated Behavior Scale
 CCMD: Chinese Classification of Mental Disorders
 CGI: Clinical Global Impression
 CGI‐I: Clinical Global Impression – Improvement
 CGI‐S: Clinical Global Impression – Severity
 CI: confidence interval
 DSM: Diagnostic and Statistical Manual
 ECG: electrocardiogram
 ECT: electroconvulsive therapy
 EPS: Extrapyramidal Side Effects
 ICD: International Classification of Diseases
 IM: intramuscular
 OAS: Overt Aggression Scale
 PANSS: Positive and Negative Syndrome Scale
 PANSS‐EC: Positive and Negative Syndrome Scale Excited Component
 p.o.: by mouth
 RSESE: Rating Scale for Extrapyramidal Side Effects.
 SAS: Simpson‐Angus Scale
 SD: standard deviation
 SE: standard error
 TESS: Treatment Emergent Symptom Scale
 TSRS: TSRS ‐ Target Rating Symptom Scale
 YMRS ‐ Young Mania Rating Scale